OR WAIT null SECS
© 2021 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
June 01, 2020
The only way for pharma companies to know where to focus their COVID-19 R&D efforts is for the industry to have access to real-time, real-world evidence of what’s working to keep people alive, write Travis Leonardi and William Kirsh.
May 18, 2020
The need for statisticians, mathematicians, and computer and data scientists to collaborate on modern methods
for “substantial evidence” in drug development is critical.
March 01, 2020
The evolving challenges and new opportunities from the latest wave of change in clinical data management practice.
September 01, 2019
Organizations that continue to disregard the technological needs of one of the industry’s core audiences run the risk of having their trials ignored.
June 01, 2019
Undertaking an assessment of the POS can be coupled with the product profile and safety assessments of compounds prior to launching a clinical trial.
May 01, 2019
What small “nudges” can serve as reminders and relevant motivators to help patients meet their goals, talk to a physician, explore a clinical trial, or stick with a treatment?
April 01, 2019
The “citizen data scientist” is the person with no official data scientist training who uses the latest tools and technologies to handle data wrangling duties, analyze data, and create reports and models.
March 01, 2019
Patient advocacy organizations are swaying away from a traditional model of granting academic researchers to now supporting biotechnology and pharma companies.
December 01, 2018
The availability of FHIR-based APIs enabling patients to access and use their healthcare data for multiple purposes has opened a door to an entirely new world of opportunities for partnering with patients on clinical studies.
November 01, 2018
Pharma and diagnostics companies need to strengthen alignment in Alzheimer’s disease research-to help turn science and data into actionable medical innovations.